Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
10.93
-0.92 (-7.76%)
At close: Oct 1, 2026, 4:00 PM EDT
11.11
+0.18 (1.65%)
After-hours: Oct 1, 2026, 5:47 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $66.79 million as of October 1, 2026. Its market cap has decreased by -88.95% in one year.
Market Cap
66.79M
Enterprise Value
49.83M
1-Year Change
-88.95%
Ranking
Category
Stock Price
$10.93
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $66.79M, a decrease of -93.29%. That is a compound annual growth rate of -29.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 66.79M | -90.69% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 71.54M |
| MAIA Biotechnology | 71.17M |
| RenovoRx | 71.08M |
| Fortress Biotech | 69.38M |
| Cingulate | 69.07M |
| OKYO Pharma | 67.44M |
| Champions Oncology | 66.95M |
| XBiotech | 66.77M |